+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cannabis Pharmaceuticals Market - Global Forecast 2026-2032- Product Image
Cannabis Pharmaceuticals Market - Global Forecast 2026-2032- Product Image
New

Cannabis Pharmaceuticals Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010641
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cannabis pharmaceuticals market is undergoing a fundamental transformation as clinical validation and shifting regulations create new pathways for innovation, patient care, and commercial opportunity. Senior decision-makers must now navigate increased complexity in formulation strategies, regulatory compliance, and value-chain partnerships within this emerging healthcare arena.

Market Snapshot: Cannabis Pharmaceuticals Market

Between 2025 and 2026, the cannabis pharmaceuticals market expanded from USD 2.04 billion to USD 2.44 billion. This sector is forecast to grow at a sustained CAGR of 19.30%, with the market value anticipated to reach USD 7.04 billion by 2032. The outlook is supported by a combination of mounting clinical evidence, evolving regulatory structures, and strong demand for cannabis-derived therapeutics from both patients and healthcare systems. These drivers are accelerating the integration of cannabinoid-based pharmaceuticals into established care protocols and moving the industry closer to mainstream adoption.

Cannabis Pharmaceuticals Market Scope & Segmentation

  • Formulation Types: Includes capsules (hard shell, soft gel), oils (broad spectrum, full spectrum, isolate), patches, tinctures, and topicals (creams, lotions, salves), allowing for diverse patient preferences and therapeutic applications.
  • Compound Selection: Covers cannabidiol-dominant products, minor cannabinoids such as cannabigerol and cannabinol, and delta-9 tetrahydrocannabinol-based formulations, each supporting tailored clinical strategies.
  • Routes of Administration: Encompasses inhalation, oral, sublingual, transdermal, mucosal, and topical delivery options, each influencing patient experience, pharmacokinetics, and adherence.
  • Distribution Channels: Spans direct-to-patient, hospitals, retail pharmacies, clinics, and specialized care centers—ensuring products meet specific needs across diverse procurement and packaging environments.
  • End-User Environments: Addresses homecare, outpatient clinics, specialist centers, and institutional settings, all of which benefit from customized compliance, support mechanisms, and integration into care systems.
  • Regional Coverage: Includes North America, Europe, Middle East & Africa, and Asia-Pacific, where localization, regulatory climates, and clinical prescribing patterns demonstrate significant variation.
  • Technology Enablers: Incorporates standardized excipient strategies, GMP-compliant analytic methodologies, contract manufacturing organizations, digital adherence tools, and advanced supply chain analytics—helping to ensure reliable quality and traceability across the value chain.

Key Takeaways for Senior Decision-Makers

  • Therapeutic development is now grounded in robust clinical findings around selected cannabinoids, promoting R&D focused on disease-specific treatments and consistent patient outcomes.
  • Advancements in formulation technology improve pharmacokinetics, tolerability, and dosage flexibility, supporting enhanced clinical utility and greater patient engagement.
  • Strengthening regulatory frameworks enable differentiation through product quality, manufacturing standards, and comprehensive evidence, facilitating faster clinical integration and broader commercial uptake.
  • Segmented product strategies and intentional distribution models help organizations align with institutional procurement cycles and workflow expectations in diverse clinical environments.
  • Establishing institutional credibility requires transparent manufacturing data, third-party quality analytics, and proven assurance processes to secure inclusion in hospital and specialized care portfolios.

Tariff Impact on Cannabis Pharmaceuticals

New US tariff measures implemented in 2025 have catalyzed significant shifts in supply chain management for the cannabinoid pharmaceuticals segment. Companies are accelerating the localization of critical inputs and expanding their supplier base to strengthen procurement resilience. These operational adjustments impact cost structures, dictate which product formats receive investment priority, and affect sourcing strategies—such as the move toward domestic manufacturing or securing long-term supplier agreements. Tariff policies are redefining competitive positioning and influencing capital investment across the industry.

Methodology & Data Sources

This report utilizes a multi-source research approach, combining in-depth clinician interviews, insights from procurement leaders and formulation scientists, and consultation with regulatory experts. Data are further validated through review of clinical trial registries, scientific literature, public company filings, and manufacturing databases. Regional policy reviews and supply chain mapping also inform the report’s comprehensive and cross-validated conclusions.

Why This Cannabis Pharmaceuticals Market Report Matters

  • Enables senior leaders to benchmark clinical, manufacturing, and regulatory trends, streamlining decision-making on resource allocation and product pipeline direction.
  • Delivers practical guidance for aligning product design and supply chain resilience with the needs of institutional buyers and healthcare stakeholders.
  • Supplies actionable insights to manage tariff effects and regional regulatory shifts—reducing risk and strengthening strategic planning across international operations.

Conclusion

Success in the cannabis pharmaceuticals sector relies on integrating clinical robustness, manufacturing excellence, and operational agility. Decision-makers who foster adaptable, evidence-driven strategies will position their organizations for sustained growth and positive clinical outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cannabis Pharmaceuticals Market, by Product Type
8.1. Capsule
8.1.1. Hard Shell
8.1.2. Soft Gel
8.2. Oil
8.2.1. Broad Spectrum
8.2.2. Full Spectrum
8.2.3. Isolate
8.3. Patch
8.4. Tincture
8.5. Topical
8.5.1. Cream
8.5.2. Lotion
8.5.3. Salve
9. Cannabis Pharmaceuticals Market, by Compound Type
9.1. CBD
9.2. THC
10. Cannabis Pharmaceuticals Market, by Route Of Administration
10.1. Inhalation
10.2. Oral
10.3. Sublingual
10.4. Topical
11. Cannabis Pharmaceuticals Market, by Application
11.1. Dermatology
11.2. Neurological Disorders
11.3. Oncology Support
11.4. Pain Management
12. Cannabis Pharmaceuticals Market, by End User
12.1. Clinics
12.2. Homecare
12.3. Hospitals
12.4. Specialized Centers
13. Cannabis Pharmaceuticals Market, by Distribution Channel
13.1. Direct To Patient Sales
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Retail Pharmacies
14. Cannabis Pharmaceuticals Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Cannabis Pharmaceuticals Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Cannabis Pharmaceuticals Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Cannabis Pharmaceuticals Market
18. China Cannabis Pharmaceuticals Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. Aphria, Inc.
19.7. Aurora Cannabis, Inc.
19.8. Bausch Health Companies, Inc.
19.9. Botanix Pharmaceuticals
19.10. Breath of Life Pharma, Ltd.
19.11. Cannabis Science, Inc.
19.12. Cannamedical Pharma GmbH
19.13. Canopy Growth Corporation
19.14. Cara Therapeutics Inc.
19.15. CB Therapeutics Inc.
19.16. Celadon Pharmaceuticals PLC
19.17. Corbus Pharmaceuticals Holdings, Inc.
19.18. Cronos Group Inc. By Altria Group
19.19. Green Thumb Industries
19.20. Jazz Pharmaceuticals PLC
19.21. Medical Marijuana Inc.
19.22. MGC Pharmaceuticals Limited
19.23. Panaxia Pharmaceutical Industries
19.24. Pascal Biosciences Inc.
19.25. PharmaCyte Biotech, Inc.
19.26. Renew Biopharma, Inc.
19.27. Teva Pharmaceutical Industries Ltd.
19.28. Tilray Brands, Inc.
19.29. Zynerba Pharmaceuticals, Inc. by Harmony Biosciences
List of Figures
FIGURE 1. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HARD SHELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HARD SHELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HARD SHELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOFT GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOFT GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOFT GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BROAD SPECTRUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BROAD SPECTRUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BROAD SPECTRUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY FULL SPECTRUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY FULL SPECTRUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY FULL SPECTRUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ISOLATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ISOLATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ISOLATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TINCTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TINCTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TINCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBD, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY THC, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY THC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY THC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBLINGUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBLINGUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SPECIALIZED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SPECIALIZED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 149. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 150. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. EUROPE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 168. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 169. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 170. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 171. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 172. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 189. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 190. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 191. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 193. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. ASEAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 199. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 200. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 201. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. GCC CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 219. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 220. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 221. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 222. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 223. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. BRICS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 229. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 230. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 231. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 232. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 233. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. G7 CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 239. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 240. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 241. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 242. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. NATO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 257. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 258. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 259. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 260. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2032 (USD MILLION)
TABLE 261. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 262. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2032 (USD MILLION)
TABLE 263. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 264. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cannabis Pharmaceuticals market report include:
  • AbbVie Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Bausch Health Companies, Inc.
  • Botanix Pharmaceuticals
  • Breath of Life Pharma, Ltd.
  • Cannabis Science, Inc.
  • Cannamedical Pharma GmbH
  • Canopy Growth Corporation
  • Cara Therapeutics Inc.
  • CB Therapeutics Inc.
  • Celadon Pharmaceuticals PLC
  • Corbus Pharmaceuticals Holdings, Inc.
  • Cronos Group Inc. By Altria Group
  • Green Thumb Industries
  • Jazz Pharmaceuticals PLC
  • Medical Marijuana Inc.
  • MGC Pharmaceuticals Limited
  • Panaxia Pharmaceutical Industries
  • Pascal Biosciences Inc.
  • PharmaCyte Biotech, Inc.
  • Renew Biopharma, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tilray Brands, Inc.
  • Zynerba Pharmaceuticals, Inc. by Harmony Biosciences

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.44 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.04 Billion
Compound Annual Growth Rate19.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Cannabis Pharmaceuticals Market Report 2025 - Product Image

Cannabis Pharmaceuticals Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cannabis Market Report by Product Type, Application, Compound Type, Countries and Company Analysis, 2025-2033 - Product Image

Cannabis Market Report by Product Type, Application, Compound Type, Countries and Company Analysis, 2025-2033

  • Report
  • 200 Pages
  • Global
From
Cannabis Market by Compound Type, Product Type, Application, Source, and Region - Global Forecast to 2030 - Product Image

Cannabis Market by Compound Type, Product Type, Application, Source, and Region - Global Forecast to 2030

  • Report
  • 325 Pages
  • Global
From
Cannabis Extract Market Report 2025 - Product Image

Cannabis Extract Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Legal Cannabis Market - Product Image

Legal Cannabis Market

  • Report
  • 93 Pages
  • Global
From

About the Cannabis Pharmaceuticals Market

The Cannabis Pharmaceuticals market within the context of Analgesics is a rapidly growing sector of the pharmaceutical industry. Cannabis-based pharmaceuticals are used to treat a variety of conditions, including chronic pain, inflammation, and neurological disorders. These drugs are often used in combination with traditional analgesics to provide a more comprehensive approach to pain management. Cannabis-based pharmaceuticals are also being studied for their potential to reduce opioid dependence and addiction. Cannabis-based pharmaceuticals are available in a variety of forms, including oral capsules, topical creams, and sublingual sprays. These products are often formulated with other active ingredients, such as cannabinoids, terpenes, and flavonoids, to provide additional therapeutic benefits. Several companies are currently operating in the Cannabis Pharmaceuticals market, including GW Pharmaceuticals, Tilray, and Zynerba Pharmaceuticals. These companies are focused on developing and commercializing cannabis-based pharmaceuticals for the treatment of various conditions. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.